Charles River Laboratories International, Inc. (CRL)
USD 183.16
(-3.26%)
USD 183.16
(-3.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 683.89 Million | 619.64 Million | 760.79 Million | 546.57 Million | 480.93 Million | 441.14 Million |
| Net Income | 480.37 Million | 492.6 Million | 398.83 Million | 365.3 Million | 254.06 Million | 227.21 Million |
| Depreciation & Amortization | 314.12 Million | 303.87 Million | 265.54 Million | 234.92 Million | 198.09 Million | 161.77 Million |
| Deferred income taxes | -50.9 Million | -35.88 Million | -24 Million | -133 Thousand | -21.89 Million | -9.7 Million |
| Stock-based compensation | 72.04 Million | 73.61 Million | 71.47 Million | 56.34 Million | 57.27 Million | 47.34 Million |
| Change in working capital | -102.38 Million | -152.55 Million | 42.94 Million | -26.27 Million | 6.17 Million | 14.81 Million |
| Other non-cash items | -29.36 Million | -62.01 Million | 6.01 Million | -83.58 Million | -12.77 Million | -315 Thousand |
| Investing Cash Flow | -563.15 Million | -607.92 Million | -1.43 Billion | -601.54 Million | -681.5 Million | -955 Million |
| Investments in PPE | -318.52 Million | -324.73 Million | -228.77 Million | -166.56 Million | -140.51 Million | -140.05 Million |
| Acquisitions | -194.78 Million | -120.11 Million | -1.17 Billion | -418.62 Million | -515.7 Million | -824.86 Million |
| Investment purchases | -54.21 Million | -158.27 Million | -45.55 Million | -26.69 Million | -22.34 Million | -25.12 Million |
| Sales/Maturities of investments | 6.66 Million | 4.54 Million | 6.53 Million | 11.4 Million | 942 Thousand | 35.84 Million |
| Other Investing Activities | -2.29 Million | -9.34 Million | 264 Thousand | -1.06 Million | -3.88 Million | -805 Thousand |
| Financing Cash Flow | -85.52 Million | -42.39 Million | 672.59 Million | 47.24 Million | 231.93 Million | 558.05 Million |
| Debt repayment | -851.67 Million | -2.93 Billion | -6.24 Billion | -2.2 Billion | -3.12 Billion | -2.2 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -24.15 Million | -38.65 Million | -40.7 Million | -23.97 Million | -18.08 Million | -13.84 Million |
| Common Stock Issuance | 25.59 Million | 25.11 Million | 45.65 Million | 46.58 Million | 34.54 Million | 37.65 Million |
| Other Financing Activities | 790.31 Million | 2.9 Billion | 6.95 Billion | 2.27 Billion | 3.37 Billion | 2.77 Billion |
| Accounts receivables | -33.43 Million | -150.57 Million | -26.63 Million | -85.62 Million | -8.32 Million | -21.19 Million |
| Accounts payables | -20.42 Million | -2.65 Million | 44.9 Million | 748 Thousand | 29.77 Million | -12.73 Million |
| Inventory | -62.3 Million | -78.52 Million | -25.15 Million | -18.37 Million | -21.39 Million | -13.33 Million |
| Other working capital | 13.78 Million | 79.19 Million | 49.83 Million | 76.98 Million | 6.12 Million | 62.08 Million |
| Cash at beginning of period | 241.21 Million | 246.31 Million | 233.11 Million | 240.04 Million | 197.31 Million | 166.33 Million |
| Cash at end of period | 284.48 Million | 241.21 Million | 246.31 Million | 233.11 Million | 240.04 Million | 197.31 Million |
| Capital Expenditure | -318.52 Million | -324.73 Million | -228.77 Million | -166.56 Million | -140.51 Million | -140.05 Million |
| Effect of forex changes on cash | 8.04 Million | 25.57 Million | 17.73 Million | 794 Thousand | 11.35 Million | -9.47 Million |
| Net cash flow / Change in cash | 43.26 Million | -5.1 Million | 13.19 Million | -6.92 Million | 42.72 Million | 30.98 Million |
| Free Cash Flow | 365.37 Million | 294.9 Million | 532.02 Million | 380.01 Million | 340.42 Million | 301.08 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 89.98 Million | 72.96 Million | 188.95 Million | 480.37 Million | 88.02 Million | 99.44 Million |
| Depreciation & Amortization | 86.08 Million | 85.35 Million | 80.51 Million | 314.12 Million | 78.87 Million | 77.67 Million |
| Deferred income taxes | -12.08 Million | -987 Thousand | -22.65 Million | -50.9 Million | -11.69 Million | -4.97 Million |
| Stock-based compensation | 16.58 Million | 16.73 Million | 19.52 Million | 72.04 Million | 22.79 Million | 16.27 Million |
| Change in working capital | -11.33 Million | -48.09 Million | 38.38 Million | -102.38 Million | 2.3 Million | -51.13 Million |
| Other non-cash items | 188.43 Million | 211.58 Million | -83.78 Million | -29.36 Million | 25.15 Million | 10.84 Million |
| Investing Cash Flow | -61.86 Million | -85.79 Million | -238.37 Million | -563.15 Million | -79.55 Million | -76.6 Million |
| Investments in PPE | -39.48 Million | -79.14 Million | -78.32 Million | -318.52 Million | -65.94 Million | -67.38 Million |
| Acquisitions | -5.47 Million | - | -144.61 Million | -194.78 Million | 65.94 Million | -74.87 Million |
| Investment purchases | -21.67 Million | -13.86 Million | -17.89 Million | -54.21 Million | -13.63 Million | -10.11 Million |
| Sales/Maturities of investments | 4.85 Million | 7.5 Million | 2.71 Million | 6.66 Million | 1.01 Million | 990 Thousand |
| Other Investing Activities | -87 Thousand | -283 Thousand | -250 Thousand | -2.29 Million | -66.93 Million | 74.77 Million |
| Financing Cash Flow | -285.85 Million | 18.34 Million | 123.56 Million | -85.52 Million | -162.86 Million | -71.46 Million |
| Debt repayment | -254.54 Million | -8.39 Million | -320.76 Million | -851.67 Million | -213.86 Million | -159.72 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -8.91 Million | -9.35 Million | -139 Thousand | -24.15 Million | -38 Thousand | -4.96 Million |
| Common Stock Issuance | 826 Thousand | 21.5 Million | 5.93 Million | 25.59 Million | 3.93 Million | 3.92 Million |
| Other Financing Activities | -23.22 Million | -2.2 Million | 444.47 Million | 790.31 Million | 51.03 Million | 93.22 Million |
| Accounts receivables | 18.35 Million | -17.28 Million | 25.64 Million | -33.43 Million | -10.83 Million | -14.41 Million |
| Accounts payables | 2.1 Million | -8.54 Million | 6.1 Million | -20.42 Million | -1.54 Million | 16.32 Million |
| Inventory | 4.15 Million | 5.6 Million | -18.17 Million | -62.3 Million | -11.45 Million | -24.08 Million |
| Other working capital | -35.94 Million | -27.87 Million | 24.81 Million | 13.78 Million | 26.14 Million | -28.95 Million |
| Cash at beginning of period | 337.36 Million | 282.57 Million | 165.61 Million | 241.21 Million | 208.77 Million | 208.89 Million |
| Cash at end of period | 179.53 Million | 337.36 Million | 284.48 Million | 284.48 Million | 165.61 Million | 208.77 Million |
| Capital Expenditure | -39.48 Million | -79.14 Million | -78.32 Million | -318.52 Million | -65.94 Million | -67.38 Million |
| Effect of forex changes on cash | -3.34 Million | -8.38 Million | 12.72 Million | 8.04 Million | -6.18 Million | -163 Thousand |
| Net cash flow / Change in cash | -157.82 Million | 54.79 Million | 118.86 Million | 43.26 Million | -43.16 Million | -114 Thousand |
| Free Cash Flow | 154.04 Million | 50.74 Million | 142.62 Million | 365.37 Million | 139.5 Million | 80.73 Million |
3698
TKM
SMAA
6705
0KW1
SRL